| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |